Method for treating parkinson's disease using apomorphine and apomorphine prodrugs
AssigneeNastech Pharmaceutical Company Inc.
InventorSteven Quay
Life of this patent
Estimating the term…
Abstract
A formulation and method for treating dopamine deficiency such as occurs in Parkinson's disease in a mammal wherein apomorphine is administered in conjunction with an apomorphine prodrug. Preferably the apomorphine prodrug is a diester of apomorphine and the mammal is a human.
Claims14
A formulation for treating a dopamine deficiency in the central nervous system in a mammal comprised of apomorphine and an apomorphine prodrug.
A method for treating a mammal having a dopamine deficiency in the central nervous system comprised of administering to said mammal therapeutically effective amounts of apomorphine in conjunction with an apomorphine prodrug.
A method for alleviating an “on-off’ episode in an individual afflicted with Parkinson's disease comprising administering apomorphine in conjunction with an apomorphine prodrug.
Dependencies are inferred from the claim text.